急性冠症候群の疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Catalyst 10
2.2 Upcoming Reports 10
3 Epidemiology 11
3.1 Disease Background 11
3.2 Risk Factors and Comorbidities 12
3.2.1 Controlling hypertension can decrease the CHD incidence by 20-25% 13
3.2.2 Every 1% decrease in cholesterol levels is associated with a 2% decrease in the CHD risk 14
3.2.3 Women who have diabetes have a higher risk of developing CHD than men with diabetes 15
3.2.4 Cigarette smoking increases the risk of CHD and also increases the risk of developing other risk factors for CHD 16
3.2.5 Obese and physically inactive persons are more likely to develop CHD through an increased risk of developing the traditional risk factors 16
3.2.6 Non-modifiable risk factors, such as family history, age, and sex, contribute to CHD development 17
3.2.7 Comorbidities 17
3.3 Global Trends – MI 18
3.3.1 MI Incidence and Mortality Trends 18
3.3.2 STEMI and NSTEMI Trends 28
3.3.3 Trends in MI Mortality and Case-Fatality Rates 30
3.3.4 MI Prevalence 32
3.4 Global Trends – UA 33
3.5 Forecast Methodology 35
3.5.1 Forecast Case Flow Map 37
3.5.2 Sources Used 43
3.5.3 Sources Not Used 52
3.5.4 Forecast Assumptions and Methods, Hospitalized MI Incident Cases 53
3.5.5 Forecast Assumptions and Methods, STEMI and NSTEMI Cases that Survived until Hospital Discharge 58
3.5.6 Forecast Assumptions and Methods, STEMI and NSTEMI Cases that Survived for One Year after Discharge 60
3.5.7 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of MI 61
3.5.8 Forecast Assumptions and Methods, Hospitalized Cases of UA 63
3.5.9 Forecast Assumptions and Methods, UA Cases that Survived until Hospital Discharge and for One Year Post-Discharge 65
3.6 Epidemiological Forecast for ACS (2013-2023) – Hospitalized Incident Cases 65
3.6.1 Hospitalized Incident Cases of ACS 65
3.6.2 Age-Specific Hospitalized Incident Cases of ACS 67
3.6.3 Sex-Specific Hospitalized Incident Cases of ACS 69
3.6.4 Hospitalized Incident Cases of ACS by STEMI, NSTEMI, and UA 71
3.6.5 ACS Cases that Survived until Hospital Discharge and for One Year 73
3.6.6 Age-Specific ACS Cases that Survived until Hospital Discharge 76
3.6.7 Age-Standardized Incidence of ACS 77
3.7 Epidemiological Forecast for MI (2013-2023) – Prevalent Cases 78
3.7.1 Diagnosed Prevalent Cases of MI 78
3.7.2 Diagnosed Prevalent Cases of MI Segmented by STEMI and NSTEMI 80
3.7.3 Age-Specific Diagnosed Prevalent Cases of MI 81
3.7.4 Sex-Specific Diagnosed Prevalent Cases of MI 83
3.7.5 Age-Standardized Diagnosed Prevalence of MI 84
3.8 Discussion 85
3.8.1 Epidemiological Forecast Insight 85
3.8.2 Limitations of the Analysis 86
3.8.3 Strengths of the Analysis 87
4 Appendix 90
4.1 Bibliography 90
4.2 About the Authors 101
4.2.1 Epidemiologists 101
4.2.2 Reviewers 101
4.2.3 Global Director of Epidemiology and Health Policy 103
4.2.4 Global Head of Healthcare 104
4.3 About GlobalData 105
4.4 About EpiCast 105
4.5 Disclaimer 106